[go: up one dir, main page]

AR070178A1 - Sal de monomaleato monohidrato como agonista del receptor 5ht1a. - Google Patents

Sal de monomaleato monohidrato como agonista del receptor 5ht1a.

Info

Publication number
AR070178A1
AR070178A1 ARP090100123A ARP090100123A AR070178A1 AR 070178 A1 AR070178 A1 AR 070178A1 AR P090100123 A ARP090100123 A AR P090100123A AR P090100123 A ARP090100123 A AR P090100123A AR 070178 A1 AR070178 A1 AR 070178A1
Authority
AR
Argentina
Prior art keywords
salt
monomaleate
monohidrate
5ht1a
receiver agonist
Prior art date
Application number
ARP090100123A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39165917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR070178(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR070178A1 publication Critical patent/AR070178A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente se refiere a una sal monomaleato monohidrato de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}4,5-dihidroimidazo[1,5-a]quinolin-3-carboxamida, a usos de la sal como un medicamento en el tratamiento de la disfuncion sexual y a composiciones farmacéuticas y formas farmaceuticas que comprenden la sal. Reivindicacion 2: La sal de acuerdo con la reivindicacion 1 que tiene una estructura cristalina caracterizada por la siguiente lista de picos de XRPD: (1)
ARP090100123A 2008-01-17 2009-01-15 Sal de monomaleato monohidrato como agonista del receptor 5ht1a. AR070178A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0800840.1A GB0800840D0 (en) 2008-01-17 2008-01-17 Novel salt

Publications (1)

Publication Number Publication Date
AR070178A1 true AR070178A1 (es) 2010-03-17

Family

ID=39165917

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100123A AR070178A1 (es) 2008-01-17 2009-01-15 Sal de monomaleato monohidrato como agonista del receptor 5ht1a.

Country Status (10)

Country Link
US (1) US20100317672A1 (es)
EP (1) EP2238136A1 (es)
JP (1) JP2011509973A (es)
AR (1) AR070178A1 (es)
CL (1) CL2009000075A1 (es)
GB (1) GB0800840D0 (es)
PE (1) PE20091373A1 (es)
TW (1) TW200942540A (es)
UY (1) UY31601A1 (es)
WO (1) WO2009090202A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Also Published As

Publication number Publication date
PE20091373A1 (es) 2009-10-14
EP2238136A1 (en) 2010-10-13
UY31601A1 (es) 2009-08-31
JP2011509973A (ja) 2011-03-31
CL2009000075A1 (es) 2011-02-11
US20100317672A1 (en) 2010-12-16
GB0800840D0 (en) 2008-02-27
TW200942540A (en) 2009-10-16
WO2009090202A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
CL2011001685A1 (es) Uso de compuestos derivados de imidazo[4,5-d]pirimidina, imidazo[4,5-d]piridazina y pirrolo[3,2-d]pirimidina oxo sustituidos, inhibidores de dpp-4, para el tratamiento de enfermedades metabolicas en pacientes pediatricos, tal como diabetes de tipo 2.
ECSP18018453A (es) Procedimiento para la preparación de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}metilcarbamato de metilo y su purificación para su uso como principio activo farmacéutico
MX2017006412A (es) Forma cristalina de sulfato acido de (s)-n-(5-((r)-2-(2,5-difluoro fenil)-pirrolidin-1-il)-pirazolo[1,5-a]-pirimidin-3-il)-3-hidroxi pirrolidina-1-carboxamida.
CL2008000690A1 (es) Compuestos derivados del acido indol-3-propionico; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hiperlipidemia, hipertension; entre otras.
DOP2013000243A (es) Inhibidores sustituidos de acetil-coa carboxilasa
PE20120602A1 (es) ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA
NZ600430A (en) Spiro-oxindole mdm2 antagonists
CL2012003227A1 (es) Compuestos macrociclicos que comprenden en el ciclo una porcion pirazolo[1,5-a]pirimidina, inhibidores de quinasa trk; composicion farmaceutica; proceso de preparación; y metodo para tratar un trastorno seleccionado de dolor, cancer, inflamacion, enfermedad neurodegenerativa o infeccion por trypanosoma cruzi.
CO6382125A2 (es) Inhibidores de proteína quinasa
NZ629432A (en) Heterocyclyl compounds as mek inhibitors
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
CL2012001714A1 (es) Compuestos derivados de pirrol[3.4-b]piridin-5-ona, inhibidores de pi3k; composicion farmaceutica que los comprende; y uso para el tratamiento de enfermedades tales como alzheimer, epilepsia, esclerosis multiple, parkinson, entre otras.
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
CR20120177A (es) Nuevos compuestos de espiropiperidina y el uso farmacéutico del mismo para el tratamiento de diabetes
DOP2011000260A (es) Pirimidinas fusionadas
AR077144A1 (es) Derivado de fenilimidazol como inhibidor de la enzima pde10a, composiciones farmaceuticas y uso de los mismos en el tratamiento de trastornos neurodegenerativos y psiquiatricos
MX340574B (es) Imidazo pirazinas.
EA201400067A1 (ru) Новая терапевтическая композиция, содержащая апоморфин в качестве активного ингредиента
CL2016001421A1 (es) Derivados de [1,2,4] triazolo [1,5-a] pirimidina como inhibidores de proteasoma para el tratamiento de enfermedades parasitarias como la leishmaniasis.
CU20120081A7 (es) Nuevas formas polimorfas de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
CO6460763A2 (es) Métodos y formulaciones ectoparasiticidas
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
CR20110023A (es) Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal